LABT EFFECT: SEC filing
Lakewood-Amedex Biotherapeutics Inc.
Filed with the SEC on · accession 9999999995-26-003056
LABT filed a EFFECT (effect) with the SEC on Sep 24, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.7% by the first close after the filing.
Summary of the filing
Lakewood-Amedex Biotherapeutics Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
Key details
How LABT stock reacted
Close before
$1.78
Sep 23, 2026
First close after
+1.69%
$1.81
5 trading days
-46.33%
$0.96
Since filing
-77.53%
$0.40
✦ Ask GOAX AI about this filing — what it means for LABT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LABT?
Click hereFrequently asked questions
What did LABT file with the SEC on Sep 24, 2026?
LABT filed a EFFECT (SEC filing). Lakewood-Amedex Biotherapeutics Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
How do I read a EFFECT?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
How did LABT stock react to this filing?
LABT closed at $1.78 before the filing and $1.81 on Sep 24, 2026 (+1.69%). Five trading days later: $0.96 (-46.33%).
Other LABT SEC filings
Get alerts when LABT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days